Alchemy Partners is a private equity firm that targets investments in the UK, Ireland, and German speaking Europe. Alchemy looks to commit £25 to £150 million per transaction in areas including financial services, information technology and telecoms. Historically, the Firm primarily targeted leveraged buyouts, buy-ins, and growth capital financings, but today Alchemy specializes in distressed and undervalued or underperforming businesses. Alchemy Partners was formed in 1997 and is based in London.
Join Mergr to view the latest updates and news from London-based Alchemy Partners.
Alchemy Partners’ most common sectors for investment are financial services (14%) and information technology (14%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (60%) and secondary buyout (14%). In total, Alchemy Partners has invested in 2 US states and 5 different countries. Its largest (disclosed) acquisition occurred in 2012 when it acquired Four Seasons Health Care for $1.3B.
In the last 3 years, Alchemy Partners has exited 1 company. The Firm’s most common exit type is trade sale (72%). Alchemy Partners’ largest (disclosed) exit occurred in 2008 when it sold CompAir for $308M.
Join Mergr to view Alchemy Partners’ full profile and discover more large private equity firms just like it.
No obligation. Cancel anytime.